KRMD

$4.21-0.09 (-2.09%)

Market ClosedAs of Mar 20, 8:00 PM UTC

KORU Medical Systems, Inc.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPROTranscriptsPROStatementsPRO

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$4.21
Potential Upside
5%
Whystock Fair Value$4.42
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Instruments & Supplies

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to del...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$195.22M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.50
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-22.55%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.92

Recent News

Zacks
Mar 20, 2026

Phreesia (PHR) Stock Jumps 5.1%: Will It Continue to Soar?

Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 17, 2026

KORU Medical Secures EU MDR Certification for Freedom60 Infusion Pump

KRMD secures EU MDR certification for its Freedom60 Infusion Pump, opening broader EU access and boosting adoption of patient-friendly home infusion solutions.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Mar 13, 2026

KORU Medical Systems, Inc. Q4 2025 Earnings Call Summary

Moby summary of KORU Medical Systems, Inc.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Mar 13, 2026

KORU Medical Systems Inc (KRMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

KORU Medical Systems Inc (KRMD) reports a 22% revenue increase and new pharma collaborations, despite facing geopolitical and market challenges.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 13, 2026

KORU Medical Systems Q4 Earnings Call Highlights

KORU Medical Systems (NASDAQ:KRMD) reported fourth-quarter and full-year 2025 results that management said reflected continued share gains in its core subcutaneous immunoglobulin (SCIG) business, accelerating international growth, and progress expanding its Freedom Infusion System platform into addi

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.